Abstract:INTRODUCTION AND OBJECTIVES: Bone morphogenetic protein (BMP)-2, a member of the transforming growth factor b superfamily, has been shown to act as a tumor suppressor in several cancers by activating signaling cascades that cause cell cycle arrest. In addition, the expression level of BMP-2 is downregulated because of promoter CpG hypermethylation. We hypothesized that impaired regulation of BMP-2 through epigenetic pathways is associated with the pathogenesis of renal cell carcinoma. METHODS: To test this hypothesis, CpG methylation of the BMP-2 gene was analyzed in 3 renal tumor cell lines and 96 renal tumor and matched normal renal tissue. Promoter CpG methylation was analyzed by methylation specific PCR using bisulfite-modified DNA as template. BMP-2 expression was measured by quantitative RT-PCR. RESULTS: BMP-2 mRNA expression was significantly enhanced after 5-aza-2€ uf-deoxycytidine treatment in renal tumor cell lines. The prevalence of BMP-2 promoter methylation was significantly higher and BMP-2 mRNA expression was significantly lower in renal tumor samples than in normal kidney samples (p<0.0001, p1⁄40.014, respectively). Furthermore, a significant correlation was found between BMP-2 promoter methylation and mRNA transcription in the tumors (p<0.001). A significant association of BMP-2 methylation was found with pathologic findings showing pT category and infiltrative growth pattern (p1⁄40.034). When the expression level of the BMP-2 mRNA transcript was divided into 2 groups based on the mean value, a lower expression was significantly associated with overall survival (OS) after a radical nephrectomy (p1⁄40.004). Although both promoter CpG methylation and BMP-2 mRNA transcript level were significantly associated with OS in univariate analysis, BMP-2 mRNA expression was shown to be a more significantly independent predictor for OS than methylation status in multivariate analysis. CONCLUSIONS: This is the first clinical study of inactivation of the BMP-2 gene via epigenetic pathways in renal cell carcinoma. Aberrant BMP-2 methylation and the resultant loss of BMP-2 expression might become useful as a molecular marker for prediction of OS after a radical nephrectomy.

Bone Morphogenetic Protein 2 Mediates Epithelial-Mesenchymal Transition Via AKT and ERK Signaling Pathways in Gastric Cancer.

Effect of Bone Morphogenetic Protein-2 on Proliferation and Apoptosis of Gastric Cancer Cells

Regulation of BMP2K in AP2M1-mediated EGFR Internalization During the Development of Gallbladder Cancer

BMP4 promotes the metastasis of gastric cancer by inducing epithelial-mesenchymal transition via Id1.

Deregulated Bone Morphogenetic Proteins and Their Receptors Are Associated with Disease Progression of Gastric Cancer.

Gastrokine-2 Suppresses Epithelial Mesenchymal Transition Through PI3K/AKT/GSK3β Signaling in Gastric Cancer

Bone Morphogenetic Protein‐2 Promotes Osteosarcoma Growth by Promoting Epithelial‐mesenchymal Transition (EMT) Through the Wnt/β‐catenin Signaling Pathway

How BMP-2 Induces EMT and Breast Cancer Stemness Through Rb and CD44?

BMP2 induces PANC-1 cell invasion by MMP-2 overexpression through ROS and ERK.

BMP2 as a promising anticancer approach: functions and molecular mechanisms

Inhibition of Bone Morphogenetic Protein Receptor 2 Suppresses Pancreatic Ductal Adenocarcinoma Growth by Regulating GRB2/PI3K/AKT Axis

TGFβ1 Upregulates Expression of MMP-2 and MMP-9 Through ERK Signaling Pathway in Gastric Carcinoma Cells

Role of Epithelial-Mesenchymal Transition in Gastric Cancer Initiation and Progression

MP23-19 EZH2 CONTRIBUTES TO PROLIFERATION AND METASTASIS IN RENAL CELL CARCINOMA CELLS

KBTBD2 promotes proliferation and migration of gastric cancer via activating EGFR signaling pathway

EphA2 Promotes Epithelial–mesenchymal Transition Through the Wnt/β-catenin Pathway in Gastric Cancer Cells

BMP2 Promotes Proliferation and Invasion of Nasopharyngeal Carcinoma Cells Via Mtorc1 Pathway.

[High expression of CAMSAP2 promotes invasion and metastasis of gastric cancer cells by upregulating TGF-β signaling]

Bone morphogenetic protein 2 inhibits the proliferation and growth of human colorectal cancer cells.

Bone Morphogenetic Protein 4 Induces Epithelial-Mesenchymal Transition Through Msx2 Induction on Pancreatic Cancer Cell Line

NR2F1-AS1/miR-190a/PHLDB2 Induces the Epithelial–Mesenchymal Transformation Process in Gastric Cancer by Promoting Phosphorylation of AKT3